HomeTagsXARELTO

XARELTO

Biotechnology

FDA Approves Two New Indications for XARELTO (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients

PR Newswire - December 21, 2021

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO...

spot_img

Hot Topics

RTX’s Collins Aerospace announces avionics modernization program for King Air and Hawker aircraft

Aptar and Nadara Collaborate to Drive Renewable Energy Generation in Europe

KalVista Appoints Jeb Ledell as Chief Operating Officer